Study of Anti-HIV Cellular Therapy Based on Dendritic Cells Pulsed With Chemically Inactivated Virus

Inclusion Criteria: * patients with HIV infection; * absence of antiretroviral therapy, antineoplastic therapy or the use of corticosteroids for at least six months prior to study entry; * plasma viral load ≥ 1,000 copies / mL, stable (ie no variation \> 0.5 log) in the six months before the start of the study; * blood CD4+ T cells ≥ 350 /mL, stable (ie no variation \> 25%) in the six months before the start of the study. Exclusion Criteria: * individuals without proper venous access for blood and apheresis collection procedure. * use of drugs, alcohol, psychiatric disorder or any condition that interferes with the ability of patients to follow the requirements of the study; * history of diagnosis of HIV infection \<01 years; * pregnancy or breast-feeding; * use of antiviral therapy, in anticancer therapies or corticosteroids six months prior to study start; * presence of chronic diseases, such as infection with hepatitis B (HBV) and C (HCV), human T-lymphotropic virus (HTLV) I / II or any condition that promotes immune system dysfunction, with the exception of HIV infection.